CytoReason
Latest round
- Series B
Last raised
- Jul 2024
Total raised
- $80M
Investors
- 4
About CytoReason
Founded in 2016 in Tel Aviv, Israel, CytoReason Ltd. develops advanced disease modeling platforms.CytoReason specializes in advanced AI-driven disease models that facilitate the modeling and comparison of human diseases, treatments, and patient demographics. Their core product offering is a comprehensive platform that integrates live human data to provide insights into disease mechanisms and drug efficacy. This technology enables pharmaceutical companies, biotechs, and research institutions to prioritize drug development programs, optimize treatment strategies, and enhance patient outcomes through data-driven decision-making. CytoReason's client base includes notable organizations in the healthcare sector, including partnerships with major pharmaceutical companies.CytoReason generates revenue primarily through collaborations and licensing agreements with pharmaceutical and biotechnology firms, engaging in B2B transactions where clients subscribe to access its disease modeling platform. Collaborations may involve licensing proprietary disease models tailored for specific therapeutic areas, such as inflammatory bowel disease (IBD), which can be part of multi-million USD agreements. These partnerships often include ongoing support and updates to the models to align with the latest clinical data, fostering continuous engagement with clients. The company is targeting entry into additional markets in Asia and South America, aiming for significant presence by 2025.
Who invested in CytoReason
4 investors across 1 round
See all investors in CytoReason
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jul 17, 2024
Amount
$80M
Investors
Questions about CytoReason
Who invested in CytoReason?
CytoReason has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CytoReason raised?
CytoReason has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CytoReason last raise money?
CytoReason's most recent round on record is a Series B, in Jul 2024.
What does CytoReason do?
Founded in 2016 in Tel Aviv, Israel, CytoReason Ltd.
Where is CytoReason headquartered?
CytoReason is headquartered in Tel Aviv, Israel.
Which VCs invest in companies like CytoReason?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back healthcare it companies at CytoReason's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like CytoReason? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.